In the present study, immunohistochemisty was applied to examine the level of Wee1 in a panel of benign nevi and primary – and metastatic melanomas, as well as in one sample of isolated normal melanocytes, in order to evaluate the impact of altered expression on disease progression and clinical outcome. Here, WEE1 is linked to melanoma.